留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

烟碱致动脉粥样硬化的N胆碱受体信号通路

刘佃花,  张恩晖,  刘冲,  范博士,  蔡国君

downloadPDF
文章导航 > 药学实践与服务  > 2014 >  32(2): 81-84
刘佃花, 张恩晖, 刘冲, 范博士, 蔡国君. 烟碱致动脉粥样硬化的N胆碱受体信号通路[J]. 药学实践与服务, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
引用本文: 刘佃花, 张恩晖, 刘冲, 范博士, 蔡国君. 烟碱致动脉粥样硬化的N胆碱受体信号通路[J]. 药学实践与服务, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
shu
LIU Dianhua, ZHANG Enhui, LIU Chong, FAN Boshi, CAI Guojun. Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
Citation: LIU Dianhua, ZHANG Enhui, LIU Chong, FAN Boshi, CAI Guojun. Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
shu

烟碱致动脉粥样硬化的N胆碱受体信号通路

doi: 10.3969/j.issn.1006-0111.2014.02.001

  • 第二军医大学药学院药理学教研室, 上海 200433

基金项目: 国家自然科学基金(81273503).

Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic

  • Department of Pharmacology, Second Military Medical University, Shanghai 200433, China

  • 摘要: 动脉粥样硬化是一种血管炎症性疾病。烟碱(尼古丁)是香烟的主要成分之一,是许多心血管疾病(如动脉粥样硬化)的致病危险因素。最近的研究表明,烟碱可与细胞表面的烟碱型乙酰胆碱受体(nAChR)高度结合并加速动脉粥样硬化的发展,nAChR在血管的各类细胞中都有不同量的表达。因此,本综述总结nAChR及配体在烟碱致动脉粥样硬化的发病机制中的作用,以及基于nAChR的信号通路在相关细胞 (如血管平滑肌细胞、内皮细胞、血小板及免疫细胞)中对动脉粥样硬化的作用,同时讨论这些通路是如何影响斑块的稳定和发展的。最后将讨论nAChR作为治疗动脉粥样硬化分子靶点的可能性。
    Abstract: Objective Atherosclerosis is an inflammatory disease in the vessel wall. Nicotine, a major component of cigarette smoke, is an independent risk factor for cardiovascular diseases including atherosclerosis. Recent studies have shown that nicotine (the addictive component of cigarettes) binds to high affinity cell-surface receptors and accelerates the atherogenic process. These receptors were called nicotinic acetylcholine receptors (nAChR) and expressed ubiquitously in almost all cells existing in the blood vessels. Therefore, the pro-atherogenic effects of nAChR pathway ligands were summarized which would enhance the understanding of the role of nicotine and nAChR in the pathophysiology of atherosclerosis. The signaling pathways underlying nAChR subunits in cells were described that play an important role in atherosclerosis, i.e. VSMCs, endothelial cells, platelets and immune cells. How these pathways converge on the growth and survival of atheromatous plaques were also discussed. Finally, the feasibility of nAChR ligands as therapeutic targets for atherosclerosis was summarized.
  • [1] Stylianou IM, Bauer RC, Reilly MP, et al. Genetic basis of atherosclerosis:Insights from mice and humans[J].Circ Res, 2012,110(2):337-355.
    [2] Doyle B, Caplice N. Plaque neovascularization and antiangiogenic therapy for atherosclerosis[J].J Am Coll Cardiol, 2007,49(21):2073-2080.
    [3] Unverdorben M, von Holt K, Winkelmann BR. Smoking and atherosclerotic cardiovascular disease:PartⅡ:role of cigarette smoking in cardiovascular disease development[J].Biomark Med, 2009,3(5):617-653.
    [4] Santanam N, Thornhill BA, Lau JK, et al. Nicotinic acetylcholine receptor signaling in atherogenesis[J].Atherosclerosis, 2012;225:264-273.
    [5] Egleton RD, Brown KC, Dasgupta P. Angiogenic activity of nicotinic acetylcholine receptors:implications in tobacco-related vascular diseases[J].Pharmacol Ther, 2009,121(2):205-223.
    [6] Ulloa L. The vagus nerve and the nicotine anti-inflammatory pathway[J].Nat Rev, 2005,4:673-684.
    [7] Cucina A, Fuso A, Coluccia P, et al. Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor[J].J Surg Res, 2008,150(2):227-235.
    [8] Strohschneider T, Oberhoff M, Hanke H, et al. Effect of chronic nicotine delivery on the proliferation rate of endothelial and smooth muscle cells in experimentally induced vascular wall plaques[J].Clin Invest, 1994,72(11):908-912.
    [9] Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis[J].Nat Med, 2001,7(7):833-839.
    [10] Lau PP, Li L, Merched AJ, Zhang AL, et al. Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice[J].Arterioscler Thromb Vasc Biol, 2006,26(1):143-149.
    [11] Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial diseas[J].Nature, 2008,452(7187):638-642.
    [12] Wang Z, Wu W, et al. NF-ΚB pathway mediates vascular smooth muscle response to nicotine[J].Int J Biochem Cell Biol, 2012,45 (2):375-383.
    [13] Chan SM, Ermann J, Su L, et al. Protein microarrays for multiplex analysis of signal transduction pathways[J].Nat Med, 2004,10(12),1390-1396.
    [14] Wu JC, Chruscinski A, De Jesus Perez VA, et al. Cholinergic modulation of angiogenesis:role of the 7 nicotinic acetylcholine receptor[J].J Cell Biochem, 2009, 108(2):433-446.
    [15] Kanda Y, Watanabe Y. Nicotine-induced vascular endothelial growth factor release via the egfrerk pathway in rat vascular smooth muscle cells[J].Life Sci, 2007, 80(15):1409-1414.
    [16] Bucerius J, Manka C, Schmaljohann J, et al. Feasibility of [18F]-2-fluuoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo[J].JACC Cardiovasc Imaging, 2012,5(5):528-536.
    [17] Cooke JP. Imaging vascular nicotine receptors:a new window onto vascular disease[J].JACC Cardiovasc Imaging, 2012,5(5):537-539.
    [18] Zhang G, Marshall AL, Thomas AL, et al. In vivo knockdown of nicotinic acetylcholine receptor alpha1 diminishes aortic atherosclerosis[J].Atherosclerosis, 2011,215(1):34-42.
    [19] Li S, Zhao T, Xin H, et al. Nicotinic acetylcholine receptor alpha7 subunit mediates migration of vascular smooth muscle cells toward nicotine[J].J Pharmacol Sci, 2004,94(3):334-338.
    [20] Cooke JP, Ghebremariam YT. Endothelial nicotinic acetylcholine receptors and angiogenesis[J].Trends Cardiovas Med, 2008, 18(7):247-253.
  • [1] 张成中, 朱雪艳, 卜其涛, 王宏瑞, 黄宝康.  基于网络药理学与分子对接预测鸡骨草特征图谱研究 . 药学实践与服务, 2024, 42(7): 1-9. doi: 10.12206/j.issn.2097-2024.202303048
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  2681
  • HTML全文浏览量:  228
  • PDF下载量:  81
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-07-28
  • 修回日期:  2013-10-14

烟碱致动脉粥样硬化的N胆碱受体信号通路

doi: 10.3969/j.issn.1006-0111.2014.02.001
  • 第二军医大学药学院药理学教研室, 上海 200433
    • 基金项目:  国家自然科学基金(81273503).
  • 收稿日期: 2013-07-28
  • 修回日期: 2013-10-14

摘要: 动脉粥样硬化是一种血管炎症性疾病。烟碱(尼古丁)是香烟的主要成分之一,是许多心血管疾病(如动脉粥样硬化)的致病危险因素。最近的研究表明,烟碱可与细胞表面的烟碱型乙酰胆碱受体(nAChR)高度结合并加速动脉粥样硬化的发展,nAChR在血管的各类细胞中都有不同量的表达。因此,本综述总结nAChR及配体在烟碱致动脉粥样硬化的发病机制中的作用,以及基于nAChR的信号通路在相关细胞 (如血管平滑肌细胞、内皮细胞、血小板及免疫细胞)中对动脉粥样硬化的作用,同时讨论这些通路是如何影响斑块的稳定和发展的。最后将讨论nAChR作为治疗动脉粥样硬化分子靶点的可能性。

English Abstract

刘佃花, 张恩晖, 刘冲, 范博士, 蔡国君. 烟碱致动脉粥样硬化的N胆碱受体信号通路[J]. 药学实践与服务, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
引用本文: 刘佃花, 张恩晖, 刘冲, 范博士, 蔡国君. 烟碱致动脉粥样硬化的N胆碱受体信号通路[J]. 药学实践与服务, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
shu
LIU Dianhua, ZHANG Enhui, LIU Chong, FAN Boshi, CAI Guojun. Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
Citation: LIU Dianhua, ZHANG Enhui, LIU Chong, FAN Boshi, CAI Guojun. Signaling pathway of acetylcholine receptors in atherosclerosis induced by nicotinic[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(2): 81-84. doi: 10.3969/j.issn.1006-0111.2014.02.001
shu

    全文HTML

参考文献 (20)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计